Literature DB >> 16440219

MRI and CT revealing carcinoid heart disease.

Nico R Mollet1, Steven Dymarkowski, Jan Bogaert.   

Abstract

Carcinoid heart disease is a frequent complication of the carcinoid syndrome, usually presenting as right-sided valvular heart disease. Although the diagnosis is most often made with cardiac ultrasound, MRI and CT are valuable techniques for diagnosing carcinoid heart disease.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 16440219     DOI： 10.1007/s00330-002-1806-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


  6 in total

Review 1.  A unique heart disease associated with a unique cancer: carcinoid heart disease.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1997-07-15       Impact factor: 2.778

2.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

3.  Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.

Authors:  P A Pellikka; A J Tajik; B K Khandheria; J B Seward; J A Callahan; H C Pitot; L K Kvols
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

4.  Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.

Authors:  P A Robiolio; V H Rigolin; J S Wilson; J K Harrison; L L Sanders; T M Bashore; J M Feldman
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

5.  MR and CT diagnosis of carcinoid heart disease.

Authors:  S A Mirowitz; F R Gutierrez
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

6.  Outcome of cardiac surgery for carcinoid heart disease.

Authors:  H M Connolly; R A Nishimura; H C Smith; P A Pellikka; C J Mullany; L K Kvols
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094
  6 in total
  8 in total

1.  Evaluation of carcinoid heart disease using delayed enhancement imaging.

Authors:  M Hrabak-Paar; R Stern-Padovan
Journal:  Ir J Med Sci       Date:  2010-12-12       Impact factor: 1.568

Review 2.  Cardiac and pericardial abnormalities on chest computed tomography: what can we see?

Authors:  J Bogaert; M Centonze; R Vanneste; M Francone
Journal:  Radiol Med       Date:  2010-01-07       Impact factor: 3.469

Review 3.  Cardiothoracic manifestations of neuroendocrine tumours.

Authors:  Ramin Mandegaran; Sarojini David; Nicholas Screaton
Journal:  Br J Radiol       Date:  2016-01-19       Impact factor: 3.039

4.  Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes.

Authors:  Ailbhe C O'Neill; Shaunagh McDermott; Carole A Ridge; David Keane; Jonathan D Dodd
Journal:  World J Cardiol       Date:  2012-05-26

5.  Echocardiographic imaging of tricuspid and pulmonary valve abnormalities in primary ovarian carcinoid tumor.

Authors:  Constantina Aggeli; Ioannis Felekos; Christina Kazazaki; Dimitrios Giannopoulos; Athanasios Kartalis; Christos Pitsavos; Christodoulos Stefanadis
Journal:  Cardiovasc Ultrasound       Date:  2010-09-02       Impact factor: 2.062

6.  Cardiac carcinoid: tricuspid delayed hyperenhancement on cardiac 64-slice multidetector CT and magnetic resonance imaging.

Authors:  R Martos; C Ridge; M Quinn; J Dodd
Journal:  Ir J Med Sci       Date:  2009-01-22       Impact factor: 1.568

7.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

Review 8.  The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment.

Authors:  Dinu Valentin Balanescu; Teodora Donisan; Juan Lopez-Mattei; Saamir Hassan; Peter Kim; Arvind Dasari; Daniel Halperin; James Yao; Biswajit Kar; Igor Gregoric; Serban Mihai Balanescu; Cezar Iliescu
Journal:  Oncol Lett       Date:  2018-11-19       Impact factor: 2.967
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.